Urinary Steroid Metabolites in Autism
Launched by INTERSCI RESEARCH ASSOCIATION, AUSTRIA · Sep 8, 2010
Trial Information
Current as of September 06, 2025
Unknown status
Keywords
ClinConnect Summary
Autism spectrum disorder presents many alterations in amino acid metabolism and in neurotransmitter systems (gamma amino acid system, glutamate-glutamine, nicotine-acid, serotonin-system) . Also alteration in gene activation within nerve cells and lymphocyte cultures encloses over 600 genes, affecting a wide field of enzymes , metabolic pathways and hormone formation. Male hormones and their precursors are often increased and their influence to nerve cell growth and spine formation is evident.
The diagnosis of autism spectrum disorder is made in accordance of criteria of the Diagnostic and...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Autism spectrum disorder
- • Age 5-15 years
- Exclusion Criteria:
- • Epilepsia
- • Psychotropic medication
- • other severe illness
About Intersci Research Association, Austria
Intersci Research Association, based in Austria, is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a strong emphasis on ethical standards and regulatory compliance, Intersci collaborates with various stakeholders to facilitate the development of novel therapies and medical interventions. The organization specializes in conducting high-quality clinical trials across diverse therapeutic areas, leveraging its expertise to enhance patient outcomes and contribute to the global healthcare landscape. Through a commitment to scientific excellence and operational efficiency, Intersci Research Association plays a pivotal role in bridging the gap between research and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leibnitz, Steiermark, Austria
Patients applied
Trial Officials
Johann Kurz, MD
Principal Investigator
Intersci Research Association, Austria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials